By: IPP Bureau
Last updated : September 30, 2025 4:11 pm
The platform integrates artificial intelligence into a unified environment that supports optical, microCT, ultrasound, and other imaging modalities
Revvity has launched Living Image Synergy AI, a next-generation multimodal analysis software designed to advance in vivo imaging research.
The platform integrates artificial intelligence into a unified environment that supports optical, microCT, ultrasound, and other imaging modalities—helping researchers streamline workflows, reduce inconsistencies, increase throughput, and improve reproducibility to accelerate scientific discovery.
“Our Living Image Synergy AI software marks a significant leap forward in preclinical imaging analysis,” said Kevin Quick, Vice President of Platforms at Revvity.
“Tracking, monitoring, and visualizing biological processes and disease progression are essential to understanding complex biology and evaluating potential therapeutics early in development. By unifying disparate analysis tools and embedding AI into existing workflows, this solution enables earlier insights, more consistent results across modalities, and greater reproducibility across studies—empowering researchers to move faster with greater confidence.”
The software eliminates the need for separate analysis tools by centralizing imaging data and enabling seamless correlation across datasets. With advanced AI algorithms, it automates image segmentation and region-of-interest quantification, reducing manual work and minimizing variability in traditionally time-consuming processes. Intuitive co-registration features and automated workflows further enhance efficiency, allowing researchers to monitor disease progression and assess therapeutic efficacy with greater accuracy and statistical confidence.
By combining intelligent automation with a unified analysis platform, Revvity aims to help researchers uncover deeper biological insights, improve data reliability, and accelerate the development of new therapies.